Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00317
|
|||||
| Drug Name |
Iron monocation
|
|||||
| Synonyms |
3ZhP; ATW 230; ATW 432; Ancor B; Ancoren 80/150; Armco iron; Atomel 28; Atomel 300M200; Atomel 500M; Atomel 95; Atomiron 44MR; Atomiron 5M; Atomiron AFP 25; Atomiron AFP 5; Carbonyl iron; Copy Powder CS 105-175; DSP 1000; DSP 128B; DSP 135; DSP 135C; DSP 138; Diseases (animal), iron overload; Diseases, iron overload; EF 1000; EF 250; EFV 200/300; EFV 250; EFV 250/400; Ed-In-Sol; Eisen; F 60 (metal); FT 3 (element); Fe-40; Fe1+; Feronate; Ferretts; Ferro-Caps; Ferro-Time; Ferrous iron; Ferrousal; Ferrovac E; Ferrum; GS 6; HF 2 (element); HL (iron); HQ (metal); HS (iron); HS 4849; Hemocyte; Hierro; Hoeganaes ATW 230; Hoeganaes EH; Iron; Iron (Fe); Iron (Fe1+); Iron ion (Fe+); Iron ion(1+); Iron standard for AAS; Iron(1+); Iron(1+) ion; Iron(III) nitrate solution; Iron, elemental; Iron, ion (Fe1+); Iron, ion (Fe1+) (8CI,9CI); LOHA; NC 100; PZh-1M3; PZh-2; PZh1M1; PZh2M; PZh2M1; PZh2M2; PZh3; PZh3M; PZh4M; PZhO; Remko; SUY-B 2; Siderol; Vitedyn-Slo; Yieronia
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Iron deficiency [ICD11:5B5K.0] | Preclinical | [1] | |||
| Therapeutic Class |
Iron Supplement
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
Fe
|
|||||
| Canonical SMILES |
[Fe]
|
|||||
| InChI |
InChI=1S/Fe
|
|||||
| InChIKey |
XEEYBQQBJWHFJM-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 7439-89-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 55.84 | Topological Polar Surface Area | 0 | ||
| Heavy Atom Count | 1 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 0 | |||
| PubChem CID | ||||||
| PubChem SID |
3325
,5953609
,6128693
,6435816
,6435818
,6435820
,6436068
,6436069
,6436071
,7433524
,8005336
,8005353
,8005513
,8005595
,819438
,820025
,821084
,821168
,821537
,823515
,823520
,824061
,824068
,824479
,824743
,825486
,826250
,826441
,827481
,827792
,829797
,829801
,829982
,831741
,832153
,832644
,834416
,835008
,835113
,835453
,835455
,837736
,838309
,838843
,839154
,839155
,839156
,839157
,839159
,841285
|
|||||
| ChEBI ID |
ChEBI:18248
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | NRAMP2 | Transporter Info | Natural resistance-associated macrophage protein 2 | Substrate | [2] | |
| SLC10A7 | Transporter Info | Sodium/bile acid cotransporter 7 | Substrate | [3] | ||
| References | ||||||
| 1 | Wikipedia: Iron | |||||
| 2 | Transmembrane topology of the mammalian Slc11a2 iron transporter. Biochemistry. 2009 Sep 8;48(35):8422-34. | |||||
| 3 | Modulation of macrophage iron transport by Nramp1 (Slc11a1). Immunobiology. 2007;212(9-10):751-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.